新基公司
US ˙ NASDAQ ˙ US1510201049
該符號不再有效

SecurityCELG / Celgene Corp.
InstitutionElkfork Partners LLC
Latest Disclosed Ownership17,974 shares
Latest Disclosed Value $ 1,785,000
Elkfork Partners LLC reports 90.89% increase in ownership of CELG / Celgene Corp.

On November 14, 2019 - Elkfork Partners LLC filed a 13F-HR form disclosing ownership of 17,974 shares of Celgene Corp. (US:CELG) valued at $1,784,818 USD as of September 30, 2019. The entity filed a previous 13F-HR on August 13, 2019 disclosing 9,416 shares of Celgene Corp.. This represents a change in shares of 90.89% during the quarter. The current value of the position is $1,945,506 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2019-11-14 2019-09-30 13F Celgene COM 151020104 17,974 8,558 90.89 1,785 105.17 0.0434
2019-08-13 2019-06-30 13F Celgene COM 151020104 9,416 -189,090 -95.26 870 -95.35 0.0213
2019-05-13 2019-03-31 13F Celgene COM 151020104 198,506 -225,412 -53.17 18,727 -31.07 0.4698
2019-02-13 2018-12-31 13F Celgene COM 151020104 423,918 -129,118 -23.35 27,169 -45.10 0.7663
2018-11-14 2018-09-30 13F Celgene COM 151020104 553,036 -43,494 -7.29 49,491 4.46 1.1765
2018-08-13 2018-06-30 13F Celgene COM 151020104 596,530 -18,018 -2.93 47,376 -13.59 1.2198
2018-05-10 2018-03-31 13F Celgene COM 151020104 614,548 4,246 0.70 54,824 -13.92 1.4777
2018-02-24 2017-12-31 13F/A-1 Celgene COM 151020104 610,302 -44,902 -6.85 63,691 -33.34 1.7271
2018-02-22 2017-12-31 13F Celgene COM 151020104 443,856 -211,348 46,321
2017-11-14 2017-09-30 13F Celgene COM 151020104 655,204 -19,778 -2.93 95,542 8.99 2.7721
2017-08-14 2017-06-30 13F Celgene COM 151020104 674,982 -20,768 -2.98 87,660 1.26 2.6418
2017-05-03 2017-03-31 13F Celgene COM 151020104 695,750 -1,760 -0.25 86,572 7.23 2.6577
2017-02-10 2016-12-31 13F Celgene COM 151020104 697,510 697,510 80,737 2.6562
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.